The original version of this article unfortunately contained an error in Figures 1A and 4C . In Fig. 1A , staining picture of DMSO group was given incorrectly the same as of the image in DMSO group in Fig. 2A , and image in Bilobalide (0.2 μm) was given mistakenly the same as of the image Bilobalide (2 days) in Fig. 2A .
In Fig. 4C immunostaining picture in DMSO was given inadvertently the same as of the image XAV939+Bilobalide.
Hence, the correct Figs. 1A and 4C was given below: Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Fig. 4
Inhibitory effect of XAV939 on bilobalide-induced neuronal differentiation of P19 cells. Cells were pretreated with or without 1 μmol/L XAV939 for 30 min before the addition of bilobalide (1 μmol/L). a, b
Western blotting confirmed that β-catenin and βIII-tubulin levels were effectively down-regulated in XAV939-treated P19 cells. c Immunofluorescence staining with β-catenin (Red) was used to assess changes in nuclear and cytoplasmic β-catenin. Scale bar 25 μm. d The examination of expression of βIII-tubulin using immunofluorescence staining. Scale bar 50 μm. All values were reported as mean ± SD. **P < 0.01 versus DMSO group (Color figure online) 
